Shares of Granules India Limited touched a day high of Rs 797.00 on 3 June after the company disclosed that its wholly owned US subsidiary, Granules Pharmaceuticals Inc. (GPI), received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration for its Chantilly, Virginia facility. The USFDA classified the inspection outcome as…
December 12, 2025December 12, 2025 Shares of Indoco Remedies Ltd rallied 4% on 12 December after the company announced receiving an Establishment Inspection Report (EIR) from the US Food and Drug Administration. The company has received the EIR for its Patalganga-based Active Pharmaceutical Ingredients (API) production plant, following a…
October 1, 2024October 1, 2024 Shares of Zydus Lifesciences were trading higher by 1% on 1 October after the company announced that it had received an ‘Establishment Inspection Report (EIR)’ from the USFDA (United States Food and Drug Administration). The US health regulator conducted an inspection at the company’s…